Figure 2. Series of surveillance bone scans

Slides:

Advertisements

Similar presentations

Treatment Management of Rheumatoid Arthritis. Findings and In Depth Analysis.

Advertisements

ESMO 2011 Lung Cancer AVAPERL Study Authors: Dr. Sunil Verma Date posted: September 28 th, 2011.

and Statistics, 2016, Vol. 4, No. 1, 1-8. doi: /ajams-4-1-1

before and after rehabilitation

Figure 2. Effect of Siberian and Panax ginseng respectively on postprandial glucose level before and after three months of intake in patients with type.

Number of brain metastasis

Figure 2. Patient`s 12 Lead Electrocardiogram when she presented with palpitations and cardiac device firing on her latest hospital admission this year.

Test (Haemodialysis patients) Controls (health care workers)

Hospital live Deliveries

Research, 2015, Vol. 3, No. 6, doi: /education

Figure 3. Comparison of class performance

Table 1. The French-American-British (FAB) classification of AML

© The Author(s) Published by Science and Education Publishing.

Figure 1. Serum creatinine trend in the patient

Table 3. Number of MS patients/ Year of diagnosis / Current Residence

Table 2. Number of MS patients/ Year diagnosis /Place of Birth

Figure 1. Cyclic voltammograms of carbon supported 10 % Pt catalysts prepared in 0.5 M H2SO4 + 1 M C2H5OH solution at 0.02 V/s scan rate at (a) rpm.

Figure D. Spine MRI 26 days after initial presentation reveals pathologic collapse of L4 with a retropulsive fracture, superimposed phlegmons bilaterally,

Table 3. Comparison of NS1 Antigen Assay and Platelet Counts

Figure 1. A: T1-weighted MRI shows enhanced lesion with peripheral edema on left frontal area, compatible with high grade glioma. B: Left frontal area.

intervals from six months to one year

Caris Molecular Intelligence®

Figure 1 Rheumatoid arthritis development over time in relation to the level of inflammation Figure 1 | Rheumatoid arthritis development over time in relation.

Stephen Ansell, MD, PhD Mayo Clinic

Clinical Updates in RA: New Developments and Insights From Washington

(A) EULAR response based on DAS28 (ESR, otherwise CRP) and (B) Boolean remission, at 6 months in patients treated with abatacept as a first-line biologic.

Nat. Rev. Rheumatol. doi: /nrrheum

© The Author(s) Published by Science and Education Publishing.

Conversion to ACPA and RF seronegative status in patients with early RA treated with abatacept+MTX compared with MTX alone. Conversion to ACPA and RF seronegative.

central venous catheter at the onset

Table 11. Chi-Square Analysis Based on Grade Shift for Study Group

No. 8, doi: /education Table 9. t-Test Analysis Based on Average Quiz Scores from Last Six Quizzes t-Test: Two-Sample Assuming Unequal.

The severity of fatigue over 8 years of disease in early rheumatoid arthritis patients. The severity of fatigue over 8 years of disease in early rheumatoid.

Figure 1. Changes of Clinical Symptoms Severity in patients on multi-strain probioticFlorasan-D or Placebo Ivashkin V. et al. The Effect of a Multi-strain.

Clinical response in patients with early and established RA at month 24. *p

© The Author(s) Published by Science and Education Publishing.

Clinical expertise of GPs and rheumatologists in differentiating patients with arthralgia. Clinical expertise of GPs and rheumatologists in differentiating.

Distribution of total possible savings (y-axis), showing how much total saving there would be if only those over £x per practice per month (x-axis) were.

Number of categories that are mentioned (0% < categories < 5%)

Table 1. Diagnostic methods for systemic fungal infection (n=70)

Entrapment Efficiency (%) ± S.D.

Table 5. Comparison of Outcome of 138 patients

Malignancy-related events over time for all-bari-RA analysis set (IR).

Staphylococcus epidermidis, Staphylococcus haemolyticus

Group Male Female Total Astrocytoma Grade 2 (%65)13 (%35)7 (%100)20

Clinical response to anti-ERBB3 mAb therapy in a patient with an advanced NRG1-rearranged non–small cell lung cancer. Clinical response to anti-ERBB3 mAb.

Satisfaction with control of RA

The proportions (and 95% CIs) of anti-CCP+/RF+, anti-CCP+/RF-, anti-CCP-/RF+ and anti-CCP-/RF- patients receiving tofacitinib 5 or 10 mg two times a day.

Number of patients treated at clinics that followed up fewer than 10 patients (2013–2016) or 20 patients (2012) and proportion of patients followed up.

Behavioral strategies

Prevalence of prescribing of different anti-diabetic medications as add-on therapy in patients with type 2 diabetes on metformin. *Other=Sum of prevalence.

Figure 3. Immunohistochemistry assay for Mfn2 in each group

Table 1. Laboratory values

Frequency distribution of the number of fulfilled classification criteria for RA (ACR 1987) in relation to the proportion of positive anti-CCP antibodies.

© The Author(s) Published by Science and Education Publishing.

A 63-year-old female with lung adenocarcinoma treated with nivolumab, who experienced pseudoprogression. A 63-year-old female with lung adenocarcinoma.

© The Author(s) Published by Science and Education Publishing.

Figure 2. MDS-T configuration for the thirteen (13) criteria (and their Place) in DPESS in Athens (NKUA) Chris P. Lamprou et al. Evaluating the effectiveness.

ADC(x 10-3 mm2 /s)±standard diviation

ADC(x 10-3 mm2 /s)±standard diviation

ACPA and RF titres in patients with early RA treated with abatacept+MTX compared with MTX alone. ACPA and RF titres in patients with early RA treated with.

© The Author(s) Published by Science and Education Publishing.

Debby P. M. van den Bogaert, MD, Ellen M

Table 4. Value creation (Y2)

© The Author(s) Published by Science and Education Publishing.

ACR20, ACR20 and ACR70 response rates (proportions of patients meeting ACR 20, 50% or 70% improvement criteria) in patients with rheumatoid arthritis randomised.

Table 4. Comparison of time-window by emergency gastroscopy

Twice daily regimen N=45 MDI regimen N=28 P Value

© The Author(s) Published by Science and Education Publishing.

© The Author(s) Published by Science and Education Publishing.

Presentation transcript:

Figure 2. Series of surveillance bone scans Figure 2. Series of surveillance bone scans. (A) At 4 months after completion of pemetrexed/cisplatin induction, bone scan showed no skeletal abnormality. (B) During the course of pemetrexed maintenance, the patient experienced arthralgia. Active arthritis was disclosed on bone scan. Clinical features and her seropositivity for RF and anti-CCP fulfilled the criteria for the diagnosis of RA. (C) Pemetrexed was switched to erlotinib targeted therapy. Hydroxychloroquine was also prescribed to treat arthropathy, which nearly resolved six months after the alternative strategy Tse-Hao Lee et al. Rheumatoid Arthritis: An Exceptional Complication of Chemotherapy in a Patient with Lung Cancer. American Journal of Medical Case Reports, 2015, Vol. 3, No. 5, 130-132. doi:10.12691/ajmcr-3-5-3 © The Author(s) 2015. Published by Science and Education Publishing.